NTC Strengthens Collaboration with Sightsavers Italia
On the occasion of World Sight Day, NTC, a renowned Italian pharmaceutical company specializing in ophthalmology, has proudly renewed its collaboration with Sightsavers Italia. This international organization has dedicated the last 75 years to preventing avoidable blindness and promoting the rights of individuals with disabilities, particularly in low-income countries.
The primary goal of this renewed partnership is to enhance the surgery for cataracts in children, a critical condition responsible for a significant percentage of childhood blindness worldwide. Cataracts can either be congenital or can develop early in life, and timely intervention is vital to prevent irreversible damage to a child’s developing vision. NTC’s CEO, Riccardo Carbucicchio, strongly emphasized, "Removing cataracts in children is a fundamental act of social and health justice. Our collaboration with Sightsavers Italia is especially meaningful as it represents a tangible step in our commitment to the United Nations' Sustainable Development Goals, particularly Goal 10, which aims to reduce inequalities. Vision should not be a privilege but an accessible right for everyone across the globe."
According to the World Health Organization, over 2.2 billion people worldwide suffer from serious vision impairment, and more than a billion of these cases are preventable. In 2024 alone, Sightsavers conducted over 497,000 cataract surgeries, restoring sight — and often dignity and independence — to many who otherwise would face life with disability.
NTC's engagement in this noble cause is part of a broader corporate social responsibility strategy, highlighting its commitment to global health. This strategy involves not only supporting cataract surgeries but also participating in research projects and improving access to innovative therapies in ophthalmology and various other therapeutic fields, including pediatrics and gynecology.
By collaborating with Sightsavers Italia, NTC reaffirms its dedication to helping vulnerable communities, with a particular focus on children’s health and access to eye care. The partnership reflects a shared vision of reducing inequalities in health access and ensuring that all children, regardless of their background, have the opportunity for a healthy future with clear vision.
About NTC
NTC is a Milan-based pharmaceutical company distributing its products through partners and distributors in over 100 countries. The company is dedicated to research, development, registration, and marketing of innovative medicines, medical devices, and supplements for ophthalmology and other therapeutic areas, including pediatrics, gynecology, and gastroenterology. NTC prides itself on offering high-quality pharmaceutical products to over 200 partners, making a significant mark in the healthcare landscape. For more information, visit
www.ntcpharma.com.